Part 3 of the "EU HTA-Webcast series"
Webcode 23122002
Dr. Thomas Ecker
Ecker + Ecker GmbH, Hamburg
CEO;
Thomas Ecker is CEO of Ecker + Ecker. Since 2004 he has focused on HTA, Pricing and Reimbursement of pharmaceuticals. In that role he has been responsible for more than 100 G-BA submissions and price negotiations. His current focus is on EU HTA strategy and dossier development.
More information please click here.
Alain Estival
Cemka, France
Co-Director Market Access
Christian Hill
MAP Patient Access, Cambridge, GREAT BRITAIN
Chief Executive Officer Christian is a seasoned Market Access professional with over 20 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications. Christian is a member of the Board of EUCOPE (European Confederation of Pharmaceutical Entrepreneurs); he is also a member of the Steering Group of EMIG (Ethical Medicines Industry Group) in the UK and Ireland.
Luis Lizán
Outcomes 10, Spain
CEO
Claudia Bertozzi
Intexo Società Benefit Srl
Senior Manager in the Intexo Market Access Business Unit, specialized in national access processes (from EMA to AIFA, early access, differentiated national pathways and related timing) with particular attention to all the connections between regulatory and access aspects. Claudia is part of Intexo transversal teams and collaborate with external experts, KOLs, academics, in a network approach.
13/12/2023
13/12/2023
09:00 am - 1:00 pm; You may dial in ...
09:00 am - 1:00 pm; You may dial in 30 min in advance
online
online
Event - 850 € plus tax
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
Event - 850 € plus tax
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
Dr. Henriette Wolf-Klein
Head of Department
+49 6221 500-680
h.wolf-klein@forum-institut.de
This webcast covers HTA procedures and alignment with the EU-HTA processes in France, Italy, Spain and UK
This webcast focuses on the national preparation for the EU HTA in France, Italy and Spain, and the influence of the EU HTA on UK HTA processes. Four national experts will provide the latest information on national procedures in the transition period as well as country-specific preparations for the EU HTA.
09:00
Dr Thomas Ecker
09:30
Christian Hill
10:20 Coffee break
10:30
Alain Estival
11:20
Claudia Bertozzi
12:10 Coffee break
12:20
Luis Lizán
13:00 End of the webcast
Overall score of all evaluations in 2022
Five stars on Trustpilot = Excellent
The online seminar with details on development, quality, CMC, approval and market access for advanced therapy medicinal ...
Learn the essentials of the MDR and how to navigate around the legislation and to apply it.
Update your knowledge: Our team of experts provides you with important and practical information about the tasks and res...
This online-seminar will provide tips on how to prepare and maintain a core PSMF as well as annexes with the relevant lo...
CMC requirements in Latin America with focus Mexico, Brazil, Colombia, Argentina, Chile, and Peru. The seminar (2 half d...
